Strategy

Aug 01, 2013
Pharmaceutical Executive
As growth in the BRICs and other emerging economies begins to stabilize, companies are finally turning their attention to Africa—a hidden trove of potential that is only as good as you make it.
Aug 01, 2013
Pharmaceutical Executive
Shire's new CEO has a simple strategy for success: Set the pace on specialty medicines, spread the positive buzz and momentum of a growth stock, and seize the opportunity to innovate.
Jul 01, 2013
Pharmaceutical Executive
The lifeblood of the life sciences industry is continuous innovation—it is not a business that can survive by standing still.
Jun 01, 2013
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Customer-focused supply-chain capabilities are becoming a more important part of a company's competitive advantage.
Jun 01, 2013
Pharmaceutical Executive
New stakeholders, innovative technologies, and emergent synergies in government are combining to build fresh momentum behind the old issue of medication adherence. The question is will Big Pharma be flexible enough to keep pace with the changes?
Jun 01, 2013
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Despite their high status, management gurus aren't always on point when it comes to pharma, writes John Ansell.
May 01, 2013
Pharmaceutical Executive
By Pharmaceutical Executive Editors
In the world of patient education, processes, policies, and oversight differ vastly. There is no overarching governance structure. There isn't an accreditation process for educational interventions or patient advocacy organizations that develop the education.
May 01, 2013
Pharmaceutical Executive
By Pharmaceutical Executive Editors
New approaches to managing reimbursements for pharmacy benefit programs are testing Big Pharma.
May 01, 2013
Pharmaceutical Executive
What is industry icon Fred Hassan's management formula for staying fresh in an era of market churn?
May 01, 2013
Pharmaceutical Executive
New research from the Tufts Center for the Study of Drug Development identifies a significant contributor to the rising cost of clinical trials—the first step in meeting a growing strategic imperative to help senior management and the regulatory community craft new approaches to make trials more efficient in delivering results to clinicians and patients.
native1_300x100
lorem ipsum